trial · primary record
Sonrotoclax
Relapsed/Refractory Multiple Myeloma
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 246 |
| Primary completion | 2026-11 |
| Primary endpoint | Part 1: Number Of Participants Experiencing Dose-limiting Toxicities (DLTs) |
| Registry ID | NCT04973605 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:06.028Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04973605
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.